|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | Glostrup University Hospital, Copenhagen |
|---|---|
| Collaborator: |
Steno Diabetes Center |
| Information provided by: | Glostrup University Hospital, Copenhagen |
| ClinicalTrials.gov Identifier: | NCT00316667 |
Purpose
The aim is to assess the population prevalence of risk factors for different chronic diseases such as cardiovascular disease, type 2 diabetes, osteoporosis, asthma, and allergy. Risk factors include genetic and serologic biomarkers, questionnaire data on health and lifestyle. There are many hypotheses under study for each research field.
| Condition |
|---|
|
Cardiovascular Disease Type 2 Diabetes Asthma Hypersensitivity Osteoporosis |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | Health2006 - an Observational Population-Based Study of Cardiovascular Disease, Type 2 Diabetes, Asthma and Allergy |
| Estimated Enrollment: | 5000 |
| Study Start Date: | June 2006 |
| Estimated Study Completion Date: | June 2008 |
A population-based random sample of persons living in Copenhagen is drawn from the Danish Civil Registration System and invited for a health examination including blood sample drawing, measurement of lung function, serologic and genetic biomarkers, questionnaires on lifestyle and health. The study will form the basis for research within many different areas such as cardiovascular disease, type 2 diabetes, asthma, and allergy.
Eligibility| Ages Eligible for Study: | 18 Years to 69 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Allan Linneberg, MD, PhD | +45 43233260 | alli@glostruphosp.kbhamt.dk |
| Denmark, Glostrup | |
| Research Centre for Prevention and Health | Recruiting |
| Copenhagen, Glostrup, Denmark, DK-2600 | |
| Contact: Allan Linneberg, MD, PhD +45 43233260 alli@glostruphosp.kbhamt.dk | |
| Principal Investigator: Allan Linneberg, MD, PhD | |
| Principal Investigator: | Allan Linneberg, MD, PhD | Glostrup University Hospital, Copenhagen |
More Information
| Study ID Numbers: | KA20060011 |
| Study First Received: | April 19, 2006 |
| Last Updated: | May 8, 2008 |
| ClinicalTrials.gov Identifier: | NCT00316667 History of Changes |
| Health Authority: | Denmark: Ethics Committee |
|
epidemiology risk factors |
|
Metabolic Diseases Immune System Diseases Bronchial Diseases Diabetes Mellitus Endocrine System Diseases Asthma Osteoporosis Bone Diseases, Metabolic Bone Diseases Hypersensitivity |
Lung Diseases, Obstructive Musculoskeletal Diseases Respiratory Tract Diseases Lung Diseases Diabetes Mellitus, Type 2 Osteoporosis, Postmenopausal Hypersensitivity, Immediate Cardiovascular Diseases Glucose Metabolism Disorders Respiratory Hypersensitivity |
